R. Terkeltaub, D. Furst, K. Bennett, K. Kook, R. Crockett et al., High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study, Arthritis & Rheumatism, vol.52, issue.Suppl, pp.1060-1068, 2010.
DOI : 10.1111/j.1445-5994.1987.tb01232.x

M. Ahern, C. Reid, T. Gordon, M. Mccredie, P. Brooks et al., DOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUT, Australian and New Zealand Journal of Medicine, vol.32, issue.3, pp.301-305, 1987.
DOI : 10.1002/j.1552-4604.1975.tb01465.x

I. Van-echteld, M. Wechalekar, N. Schlesinger, R. Buchbinder, and D. Aletaha, Colchicine for acute gout, Cochrane Database Syst Rev, vol.65, issue.4, p.6190, 2014.
DOI : 10.1002/14651858.CD006190

W. Zhang, M. Doherty, T. Bardin, E. Pascual, V. Barskova et al., EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT), Annals of the Rheumatic Diseases, vol.65, issue.10, pp.1312-1336, 2006.
DOI : 10.1136/ard.2006.055269

D. Khanna, P. Khanna, J. Fitzgerald, M. Singh, S. Bae et al., 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis, Arthritis Care & Research, vol.64, issue.Suppl, pp.1447-61, 2012.
DOI : 10.1002/art.33483

K. Spencer, A. Carr, and M. Doherty, Patient and provider barriers to effective management of gout in general practice: a qualitative study: Figure 1, Annals of the Rheumatic Diseases, vol.71, issue.9, pp.1490-1495, 2012.
DOI : 10.1136/annrheumdis-2011-200801

M. Doherty, T. Jansen, G. Nuki, E. Pascual, F. Perez-ruiz et al., Gout: why is this curable disease so seldom cured?, Annals of the Rheumatic Diseases, vol.71, issue.11, pp.1765-70, 2012.
DOI : 10.1136/annrheumdis-2012-201687

L. Harrold, K. Mazor, A. Negron, J. Ogarek, C. Firneno et al., Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire, Rheumatology, vol.52, issue.9, pp.1623-1632, 2013.
DOI : 10.1093/rheumatology/ket158

T. Pascart and R. Flipo, Gout: from international guidelines to current practice. Results from a physician questionnaire, Clinical Rheumatology, vol.52, issue.11, pp.1693-1697, 2013.
DOI : 10.1093/rheumatology/ket215

K. Boomershine, Colchicine-Induced Rhabdomyolysis, Annals of Pharmacotherapy, vol.18, issue.5, pp.824-830, 2002.
DOI : 10.1097/00000441-197603000-00014

M. Maxwell, P. Muthu, and P. Pritty, Accidental colchicine overdose. A case report and literature review, Emergency Medicine Journal, vol.19, issue.3, pp.265-272, 2002.
DOI : 10.1136/emj.19.3.265

R. Blackham, M. Little, S. Baker, B. Augustson, and G. Macquillan, Unsuspected colchicine overdose in a female patient presenting as an acute abdomen, Anaesth Intensive Care, vol.35, pp.437-446, 2007.

Y. Finkelstein, S. Aks, J. Hutson, D. Juurlink, P. Nguyen et al., Colchicine poisoning: the dark side of an ancient drug, Clinical Toxicology, vol.255, issue.5, pp.407-421, 2010.
DOI : 10.1016/0300-483X(91)90015-S

R. Terkeltaub, D. Furst, J. Digiacinto, K. Kook, and M. Davis, Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors, Arthritis & Rheumatism, vol.38, issue.8, pp.2226-2263, 2011.
DOI : 10.1016/j.semarthrit.2008.08.006

R. Curiel and N. Guzman, Challenges Associated with the Management of Gouty Arthritis in Patients with Chronic Kidney Disease: A Systematic Review, Seminars in Arthritis and Rheumatism, vol.42, issue.2, pp.166-78, 2012.
DOI : 10.1016/j.semarthrit.2012.03.013

F. Lioté, S. Lancrenon, S. Lanz, P. Guggenbuhl, C. Lambert et al., GOSPEL: Prospective survey of gout in France. Part I: Design and patient characteristics (n=1003), Joint Bone Spine, vol.79, issue.5, pp.464-70, 2012.
DOI : 10.1016/j.jbspin.2011.12.006

A. Levey, K. Eckardt, Y. Tsukamoto, A. Levin, J. Coresh et al., Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney International, vol.67, issue.6, pp.2089-100, 2005.
DOI : 10.1111/j.1523-1755.2005.00365.x

A. Levey, P. De-jong, J. Coresh, E. Nahas, M. Astor et al., The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report, Kidney International, vol.80, issue.1, pp.17-28, 2011.
DOI : 10.1038/ki.2010.483

P. Richette, M. Doherty, E. Pascual, V. Barskova, F. Becce et al., SAT0531???Updated Eular Evidence-Based Recommendations for the Management of Gout, Annals of the Rheumatic Diseases, vol.73, issue.Suppl 2, pp.783-783, 2014.
DOI : 10.1136/annrheumdis-2014-eular.5022

K. Jordan, J. Cameron, M. Snaith, W. Zhang, M. Doherty et al., British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout, Rheumatology, vol.46, issue.8, pp.1372-1376, 2007.
DOI : 10.1093/rheumatology/kem056a

S. Wallace, J. Singer, G. Duncan, F. Wigley, and R. Kuncl, Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout, J Rheumatol, vol.18, pp.264-273, 1991.

K. Matsushita, E. Selvin, L. Bash, B. Astor, and J. Coresh, Risk Implications of the New CKD Epidemiology Collaboration (CKD-EPI) Equation Compared With the MDRD Study Equation for Estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study, American Journal of Kidney Diseases, vol.55, issue.4, pp.648-59, 2010.
DOI : 10.1053/j.ajkd.2009.12.016

A. Levey, L. Stevens, C. Schmid, Y. Zhang, A. Castro et al., A New Equation to Estimate Glomerular Filtration Rate, Annals of Internal Medicine, vol.150, issue.9, pp.604-616, 2009.
DOI : 10.7326/0003-4819-150-9-200905050-00006

L. Annemans, E. Spaepen, M. Gaskin, M. Bonnemaire, V. Malier et al., Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005, Annals of the Rheumatic Diseases, vol.67, issue.7, pp.960-966, 2000.
DOI : 10.1136/ard.2007.076232

C. Scire, M. Manara, M. Cimmino, M. Govoni, F. Salaffi et al., Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR), Arthritis Research & Therapy, vol.15, issue.5, p.101, 2013.
DOI : 10.3899/jrheum.080506

A. Tufan, D. Dede, S. Cavus, N. Altintas, A. Iskit et al., Rhabdomyolysis in a Patient Treated with Colchicine and Atorvastatin, Annals of Pharmacotherapy, vol.156, issue.7-8, pp.1466-1475, 2006.
DOI : 10.1016/j.toxlet.2004.12.008

G. Alayli, K. Cengiz, F. Cantürk, D. Durmu?, Y. Akyol et al., Acute Myopathy in a Patient with Concomitant Use of Pravastatin and Colchicine, Annals of Pharmacotherapy, vol.18, issue.7-8, pp.1358-61, 2005.
DOI : 10.1592/phco.24.17.1784.52334